In the present invention, there are disclosed conditionally immortal, pluripotent, neuroepithelial cells for therapeutic use, especially for the treatment of intracerebral transplantation to recover brain function damaged by loss of cells or cell damage in an animal as well as the use of such cells in the preparation of a medicament intended for the treatment of traumatic brain injury, stroke, perinatal ischemia, including cerebral palsy, Alzheimer's, Pick's and related dementing neurodegenerative diseases, multi-infarct dementia, Parkinson's and Parkinson's type diseases, Huntington's disease, Korsakoff's disease and Creuzfeld-Jacob disease.
Conditionally immortal, pluripotent, neuroepithelial cells for therapeutic use, especially and medicament in which such cells are comprised